
Home » NASTECH PHARMA ENTERS DEVELOPMENT DEAL WITH AMYLIN PHARMA
NASTECH PHARMA ENTERS DEVELOPMENT DEAL WITH AMYLIN PHARMA
June 26, 2006
Nastech Pharmaceutical Company Inc. entered a agreement with Amylin Pharmaceuticals, Inc. to develop a nasal spray formulation of exenatide. StreetInsider.com (http://www.streetinsider.com/news.php?id=988986&st=p)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
19Jan
-
21Jan
-
26Jan
-
27Jan
-
27Jan
-
09Feb